Welcome to the world of immunohistochemistry!
📞 800-8581156 📧 info@naim.com.cn
Menu
  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Close
分类
  • Consultation and Feedback
  • Hotspot Focus
  • Immunohistochemistry and Pathology
  • Immunohistochemistry Technology Exchange
  • Industry News
  • Maxxin Dynamics
  • Meeting Notice
  • News and Information
  • Public laboratory
  • Recommended List and Introduction of Newly Developed IHC
  • Service and Support
  • Uncategorized
Product Search
06 2 月

Striving for Excellence and Approaching Perfection, Maixin Achieves Outstanding Results Again in the NordiQC 2019 Interlaboratory Quality Assessment.

Continue reading
06 2 月

Tumor Talk: Can Inflammation Turn into Cancer?

Continue reading
06 2 月

MaiXin’s Self-Developed Novel Liver Cancer Detection Kit, in Collaboration with Academician Wang Hongyang’s Team, Receives First CFDA Certification.

Continue reading
06 2 月

Companion Diagnostics Facilitate Immunotherapy, But What Is Immunotherapy?

Continue reading
06 2 月

IHC Master’s Diary: Antibody Selection

Continue reading
06 2 月

New Indicator for Pituitary Adenoma/PitNET Classification—SF-1

Continue reading
06 2 月

We sincerely wish you a happy National Day!

Continue reading
06 2 月

Invitation | The 13th Annual Meeting of the Chinese Pathologists Association & The 11th Asia-Pacific International Conference of Pathology, Maxin Welcomes Your Presence!

Continue reading
06 2 月

Twenty-eighth Issue of “Mai Mai” Pathology Weekly Reading Notes | Overview of Immunohistochemical Markers for Lymphoid Tissue Tumor Diagnosis (Part 4)

Continue reading
06 2 月

Great News: Maxin Tops the 2017 Shanghai Immunohistochemistry Quality Control and Competition

Continue reading
  • «
  • ‹
  • 28
  • 29
  • 30
  • 31
  • 32
  • ›
  • »

Copyright © 1993 - 2017 Fuzhou Maixin Biotechnology Development Co., Ltd. MinICP No. 05015562-1 | (Fujian) - Non-commercial - 2017-0010

  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Sidebar